TargetRx, Inc. Expands Management Team to Support Continued Growth
Published: Sep 14, 2009
HORSHAM, Pa.--(BUSINESS WIRE)--With a 25 percent increase in year over year revenue and a growing portfolio of pharmaceutical and biotech clients, TargetRx today announced the addition of Dave Dornstreich as vice president of business development and David Deutsch as vice president of client service and development. Each executive will play a key role in supporting the expansion of TargetRx’s customer base and leading the development of new pharmaceutical sales and marketing effectiveness solutions.